Clinical implications of the molecular genetics of chronic lymphocytic leukemia
about
A Canadian perspective on the use of immunoglobulin therapy to reduce infectious complications in chronic lymphocytic leukemiaIdentifying High-Risk Chronic Lymphocytic Leukemia: A Pathogenesis-Oriented Appraisal of Prognostic and Predictive Factors in Patients Treated with Chemotherapy with or without ImmunotherapyThe role of ATM mutations and 11q deletions in disease progression in chronic lymphocytic leukemia.Clinicopathological features and outcome of chronic lymphocytic leukaemia in Chinese patients.Serum LDH level may predict outcome of chronic lymphocytic leukemia patients with a 17p deletion: a retrospective analysis of prognostic factors in China.Distinct molecular genetics of chronic lymphocytic leukemia in Taiwan: clinical and pathogenetic implications.Modern treatment in chronic lymphocytic leukemia: impact on survival and efficacy in high-risk subgroupsNew insights into monoclonal B-cell lymphocytosis.Frequencies of SF3B1, NOTCH1, MYD88, BIRC3 and IGHV mutations and TP53 disruptions in Chinese with chronic lymphocytic leukemia: disparities with Europeans.Integration of microarray analysis into the clinical diagnosis of hematological malignancies: How much can we improve cytogenetic testing?Inter- and intra-patient clonal and subclonal heterogeneity of chronic lymphocytic leukaemia: evidences from circulating and lymph nodal compartments.Clinical impact of small subclones harboring NOTCH1, SF3B1 or BIRC3 mutations in chronic lymphocytic leukemia.Genetic lesions associated with chronic lymphocytic leukemia chemo-refractoriness.B-cell lymphoma mutations: improving diagnostics and enabling targeted therapies.Chronic lymphocytic leukemia and small lymphocytic lymphoma: two faces of the same disease.ESMO consensus conference on malignant lymphoma: general perspectives and recommendations for prognostic tools in mature B-cell lymphomas and chronic lymphocytic leukaemia.Clinical utility of recently identified diagnostic, prognostic, and predictive molecular biomarkers in mature B-cell neoplasms.Residual expression of SMYD2 and SMYD3 is associated with the acquisition of complex karyotype in chronic lymphocytic leukemia.Low-dose alemtuzumab in refractory/relapsed chronic lymphocytic leukemia: Genetic profile and long-term outcome from a single center experience.Long-term follow-up of patients with CLL treated with the selective Bruton's tyrosine kinase inhibitor ONO/GS-4059.Interphase Molecular Cytogenetic Detection Rates of Chronic Lymphocytic Leukemia-Specific Aberrations Are Higher in Cultivated Cells Than in Blood or Bone Marrow Smears.Archival bone marrow trephines are suitable for high-throughput mutation analysis using next generation sequencing technology.Functional impact of NOTCH1 mutations in chronic lymphocytic leukemia.Ibrutinib downregulates a subset of miRNA leading to upregulation of tumor suppressors and inhibition of cell proliferation in chronic lymphocytic leukemia.Ibrutinib-induced rapid response in chemotherapy-refractory Richter's syndrome.Extended follow-up and impact of high-risk prognostic factors from the phase 3 RESONATE study in patients with previously treated CLL/SLL.Elevated absolute NK cell counts in peripheral blood predict good prognosis in chronic lymphocytic leukemia.IFI16 reduced expression is correlated with unfavorable outcome in chronic lymphocytic leukemia.Telomere shortening, TP53 mutations and deletions in chronic lymphocytic leukemia result in increased chromosomal instability and breakpoint clustering in heterochromatic regions.Biallelic ATM alterations detected at diagnosis identify a subset of treatment-naïve chronic lymphocytic leukemia patients with reduced overall survival similar to patients with p53 deletion.SF3B1 mutations correlated to cytogenetics and mutations in NOTCH1, FBXW7, MYD88, XPO1 and TP53 in 1160 untreated CLL patients.NOTCH1, SF3B1, BIRC3 and TP53 mutations in patients with chronic lymphocytic leukemia undergoing first-line treatment: correlation with biological parameters and response to treatment.
P2860
Q26766388-343D0DB0-01EB-46A7-858A-2CB8191B7894Q28077136-FC49CF20-A75F-4B18-8DC1-AFEC2E1E9479Q33409459-80AE820F-2041-4F88-8A90-DF14F9CED6E6Q33648906-5B25EEB4-DBDF-4ACA-A457-9FA99B6D1D54Q33649977-10E5595F-9E90-40F9-B5BE-A8FA9A51B98BQ33746746-CAB7B38F-FDFF-4D67-8463-1C5DC355F11FQ33913537-AF793BED-F7FF-4A65-ABEF-3595111F13E8Q34256898-923D5E2B-A0C4-401A-B602-CE5842FD2A12Q35741703-E14AC444-ABC9-42D7-9699-529B0EB18BA0Q36326271-2BC9AB21-38AE-47BA-AD99-BFCA934E5108Q36520447-22EA73EF-D2A3-4CB6-8788-66E3BFA3E86BQ37216310-B1A7E2A4-5D12-40F0-8889-E8EA8EAAF3A1Q37697850-BF4FE6CE-21B4-4B42-ADAF-6AD3C80D2274Q38185363-9CC895B4-C239-4A11-9296-C2882E688E48Q39034465-B69BD93D-A122-4411-93EC-AE2E5560D567Q39324849-5ED9F3EF-3D75-47D3-9FA0-024D0DAA2E72Q39406673-0A2D078E-30A6-49A3-9A5A-A737FC407F7DQ40083143-EDE6580E-2786-46A5-B49B-BCD609D774E9Q41095380-6B3A111B-26A0-4CAC-8E95-5870DEFAB992Q42348711-CC75FD49-DA20-4568-B2AD-55E3605D4C01Q42383604-01A4A793-224A-4075-B456-0FA19FEFE588Q42583777-59BC9D79-E7CB-443B-B543-BE40EA5AB36CQ46339557-10B68435-7631-43DF-8B92-B4F31A3E385EQ46689848-D9920D64-9106-4C69-AA22-713D78D1F15FQ48168654-448FA057-A8FA-40B9-A966-5666A26E9C58Q48310393-BF7A33FC-6427-4D07-9083-49097A3B9F7FQ48312107-E42E7001-85F0-41B4-A1C0-848A0C694518Q50639003-D73F6C05-2E75-4D4C-8DB2-A4FA79E5D398Q50900368-C005BDE4-9B35-4EF5-987A-F3F2812665F6Q51587472-3E616536-ED4E-4A0C-AB2A-CC0995C8BD15Q52644149-B83569AA-14F6-4AD3-B3BF-5D09F24BFBDBQ52648282-5D555ADF-9428-4250-9409-2C086B5047A5
P2860
Clinical implications of the molecular genetics of chronic lymphocytic leukemia
description
2013 nî lūn-bûn
@nan
2013 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2013 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
name
Clinical implications of the molecular genetics of chronic lymphocytic leukemia
@ast
Clinical implications of the molecular genetics of chronic lymphocytic leukemia
@en
Clinical implications of the molecular genetics of chronic lymphocytic leukemia
@nl
type
label
Clinical implications of the molecular genetics of chronic lymphocytic leukemia
@ast
Clinical implications of the molecular genetics of chronic lymphocytic leukemia
@en
Clinical implications of the molecular genetics of chronic lymphocytic leukemia
@nl
prefLabel
Clinical implications of the molecular genetics of chronic lymphocytic leukemia
@ast
Clinical implications of the molecular genetics of chronic lymphocytic leukemia
@en
Clinical implications of the molecular genetics of chronic lymphocytic leukemia
@nl
P2093
P2860
P3181
P1433
P1476
Clinical implications of the molecular genetics of chronic lymphocytic leukemia
@en
P2093
P2860
P304
P3181
P356
10.3324/HAEMATOL.2012.069369
P407
P577
2013-05-01T00:00:00Z